Clinical trial No longer in our active list Interventional Ages 20 and up

Long-term follow-up of the Avenir Complete hip implant

Official title: Global, Multicenter, and Prospective Post-Market Clinical Follow-Up Study of the Avenir Complete™ Femoral Stem (Implants and Instrumentation)

Run by Zimmer Biomet · NCT04731077 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing how well the Avenir Complete hip implant works and stays safe for people who have had hip surgeries over a 10-year period.

More Osteoarthritis, Hip trials

Quick facts

Study typeInterventional
Ages20 Years and up
SexAll
Enrollment300 (estimated)
SponsorZimmer Biomet
Industry-sponsored
Locations9 sites (Jackson, Mississippi and 8 other locations)
Trial IDNCT04731077 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients aged 20 and older with advanced joint wear or previous hip surgery failures.

Probably not a fit

Patients with acute or chronic infections, severe vascular diseases, or insufficient bone structure near the joint may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the long-term safety, performance, and clinical benefits of the Avenir Complete femoral stem used in various hip surgeries, including total, hemi, and revision arthroplasty. The primary endpoint focuses on the survival of the implant system over a 10-year period, assessed through the Kaplan Meier method. Safety will be monitored by tracking adverse events related to the implant and procedure, while secondary endpoints will include patient-reported outcomes and radiographic assessments. The study involves patients who have experienced joint deterioration or previous hip surgery failures.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the long-term effectiveness and safety of the Avenir Complete hip implant, potentially improving patient outcomes in hip surgeries.

How similar studies have gone: Other studies on hip implants have shown promising results, indicating that this approach is supported by prior successful outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient is at least 20 years old or older and skeletally mature.
* Advanced wear of the joint due to degenerative, post-traumatic or rheumatic diseases;
* Failed previous hip surgery including

  * Joint reconstruction (osteotomy)
  * Arthrodesis
  * Hemi-arthroplasty or total hip replacement (THR)
* Acute traumatic fracture of the femoral head or neck;
* Avascular necrosis of the femoral head.
* Patients capable of understanding the surgeon's explanations and following his instructions, able and willing to participate in the follow-up program and who gave consent to take part in the study;

Exclusion Criteria:

* Acute, chronic, local, or systemic infections;
* Severe muscular, neural, or vascular diseases that endanger the limbs involved;
* Lack of bony structures proximal or distal to the joint, so that good Inclusion criteria
* Patient is at least 20 years old or older and skeletally mature.
* Advanced wear of the joint due to degenerative, post-traumatic or rheumatic diseases;
* Failed previous hip surgery including

  * Joint reconstruction (osteotomy)
  * Arthrodesis
  * Hemi-arthroplasty or total hip replacement (THR)
* Acute traumatic fracture of the femoral head or neck;
* Avascular necrosis of the femoral head.
* Patients capable of understanding the surgeon's explanations and following his instructions, able and willing to participate in the follow-up program and who gave consent to take part in the study;

Exclusion criteria

* Acute, chronic, local, or systemic infections;
* Severe muscular, neural, or vascular diseases that endanger the limbs involved;
* Lack of bony structures proximal or distal to the joint, so that good anchorage of the implant is unlikely or impossible;
* Total or partial absence of the muscular or ligamentous apparatus;
* Any concomitant diseases that can jeopardize the functioning and the success of the implant;
* Allergy to the implanted material, especially to metal (e.g. cobalt, chromium, nickel, etc.);
* Local bone tumors and/or cysts;
* Pregnancy;
* Skeletal immaturity.
* Patients unwilling or unable to give consent, or to comply with the follow-up program;
* Patients who have any condition that would - in the judgement of the Investigator - place him/her at undue risk or
* interfere with the study;
* Any vulnerable subject:

  * a prisoner
  * mentally incompetent or unable to understand what participation in the study entails
  * a known alcohol or drug abuser
  * anticipated to be non-compliant
* Patients with plans to relocate during the study follow-up period;
* Individuals whose willingness to volunteer in a clinical investigation could be unduly influenced by the expectation, whether justified or not, of benefits associated with participation or of retaliatory response from senior members of a hierarchy in case of refusal to participate;

Where it's running

  • Sykehuset Innlandet HF
    Tynset, Norway
    Recruiting
  • Sahlgrenska University Hospital - Molndal
    Molndal, Sweden
    Recruiting
  • Mississippi Sports Medicine and Orthopaedic Center PLLC
    Jackson, Mississippi, United States
    Active not recruiting
  • Heartland Regional Medical Center d.b.a. Mosaic Life Care
    Saint Joseph, Missouri, United States
    Active not recruiting
  • Orthopedic & Fracture Clinic, PC
    Portland, Oregon, United States
    Active not recruiting
  • Copenhagen University Hospital, Hvidovre
    Copenhagen, Denmark
    Active not recruiting
Show 3 more locations
  • Nissan Tamagawa Hospital
    Setagaya-Ku, Tokyo, Japan
    Active not recruiting
  • Okayama City Hospital
    Okayama, Japan
    Active not recruiting
  • Ikazia Ziekenhuis
    Rotterdam, Zuid-Holland, Netherlands
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.